Related Experiment Video
Updated: Jul 5, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Aberrant MAD2 expression in soft-tissue sarcoma
Masanori Hisaoka1, Atsuji Matsuyama, Hiroshi Hashimoto
1Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. hisaoka@med.uoeh-u.ac.jp
Abstract:
Soft-tissue sarcomas can be divided into translocation-associated (TA) and non-TA sarcomas, the latter of which is often characterized by pleomorphic cytomorphology and aneuploidy. The aberrant expression of MAD2, an essential component of the mitotic spindle checkpoint, has been recently shown to promote aneuploidy. The aim of the present paper was to assess MAD2 status on immunohistochemistry in 50 TA sarcomas with known fusion genes and 50 non-TA pleomorphic sarcomas. MAD2 was overexpressed in 26 TA (52%) and 33 non-TA sarcomas (66%). Notably, the MAD2 overexpression was frequently detected in TA sarcomas with atypical or high-grade morphology, such as round cell liposarcoma and fibrosarcomatous dermatofibrosarcoma protuberans. The MAD2 overexpression was significantly frequent in non-TA sarcomas compared with TA tumors without such atypical or high grade morphology (P = 0.012). In addition, sarcomas with MAD2 overexpression were significantly rich in abnormal mitotic figures, including multipolar mitoses and anaphase bridges, compared to MAD2-negative tumors (P = 0.003), although the overall mitotic activity was equivalent between the sarcomas with or without the MAD2 overexpression. These data suggest that the aberrant MAD2 expression is potentially associated with pleomorphic morphology and abnormal mitosis in soft-tissue sarcomas, as well as with high-grade tumor progression in its TA subset.
Insights
Aberrant expression of MAD2 (mitotic arrest deficient 2) is linked to pleomorphic morphology and abnormal mitosis in soft-tissue sarcomas. This finding is particularly relevant for high-grade translocation-associated sarcomas.
Area of Science:
- Oncology
- Cell Biology
- Molecular Pathology
Background:
- Soft-tissue sarcomas are categorized as translocation-associated (TA) or non-TA.
- Non-TA sarcomas often exhibit pleomorphic cytomorphology and aneuploidy.
- MAD2, a mitotic spindle checkpoint component, is implicated in promoting aneuploidy.
Purpose of the Study:
- To investigate MAD2 expression via immunohistochemistry in TA and non-TA soft-tissue sarcomas.
- To correlate MAD2 status with tumor morphology, grade, and mitotic abnormalities.
Main Methods:
- Immunohistochemistry was performed on 100 soft-tissue sarcoma samples (50 TA, 50 non-TA).
- MAD2 expression levels were assessed and correlated with cytomorphology, fusion gene status, and mitotic figures.
Main Results:
- MAD2 overexpression was observed in 52% of TA sarcomas and 66% of non-TA sarcomas.
- Overexpression was more frequent in high-grade TA sarcomas with atypical morphology.
- MAD2-overexpressing sarcomas showed significantly more abnormal mitotic figures (P = 0.003).
Conclusions:
- Aberrant MAD2 expression is associated with pleomorphic morphology and abnormal mitosis in soft-tissue sarcomas.
- MAD2 overexpression may contribute to high-grade progression in the TA subset of sarcomas.
Related Concept Videos
Abnormal Proliferation
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...

